CLINICAL_TRIALS
trial_result
· 2026-02-13
Clinical Trial Update: Efficacy and Safety of LX9211 in Participants With Postherpetic Neuralgia [Phase 2]
Summary
A Phase 2 trial evaluating the efficacy and safety of LX9211 in postherpetic neuralgia has completed, with results posted by the sponsor.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Lexicon Pharmaceuticals | Conditions: Postherpetic Neuralgia | Phase 2 | Status: COMPLETED | Results posted: 2026-02-13